![]() |
Volumn 64, Issue 3, 2001, Pages 257-263
|
Naltrexone potentiates anti-HIV-1 activity of antiretroviral drugs in CD4+ lymphocyte cultures
|
Author keywords
Human immunodeficiency virus; Indinavir; Naloxone; Naltrexone; Zidovudine
|
Indexed keywords
ANTIGEN P24;
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
INDINAVIR;
KAPPA OPIATE RECEPTOR;
KAPPA OPIATE RECEPTOR ANTAGONIST;
NALOXONE;
NALTREXONE;
OPIATE RECEPTOR;
ZIDOVUDINE;
ALCOHOLISM;
ANTIVIRAL ACTIVITY;
ARTICLE;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG POTENTIATION;
DRUG SAFETY;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
OPIATE ADDICTION;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
T LYMPHOCYTE;
TARGET CELL;
VIRUS CULTURE;
VIRUS EXPRESSION;
ANTI-HIV AGENTS;
CD4-POSITIVE T-LYMPHOCYTES;
CELLS, CULTURED;
DRUG COMBINATIONS;
DRUG SYNERGISM;
HIV-1;
HUMANS;
INDINAVIR;
NALOXONE;
NALTREXONE;
NARCOTIC ANTAGONISTS;
ZIDOVUDINE;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 0035500272
PISSN: 03768716
EISSN: None
Source Type: Journal
DOI: 10.1016/S0376-8716(01)00140-5 Document Type: Article |
Times cited : (27)
|
References (18)
|